Palatin concludes Phase II trial of combination therapy for obesity
"Palatin concludes Phase II trial of combination therapy for obesity" was originally created and published by Clinical Trials ...
Medscape10h
Despite Early Promise GLP-1 Disappoints in Parkinson’s Disease
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
Medscape6h
Considerations for Prescribing GLP-1s Get More Complicated
New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.
Insulin and glucose doctor urges people to try one diet to reduce need for medication
The diet, which is rich in fats and low in carbohydrates, may help alter how your body manages and utilises energy, ...
Insulin doctor says one diet 'reduces your need for medication after a few weeks'
The diet, which is rich in fats and low in carbohydrates, may help alter how your body manages and utilises energy, ...
WPSD Local 622h
The benefits and risks of GLP-1 drugs
They're known to aid in blood sugar control and, now, weight loss — but, according to a sweeping new study, the popular GLP-1 ...